Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-282019
Filing Date
2024-12-19
Accepted
2024-12-19 16:14:22
Documents
6
Effectiveness Date
2024-12-19

Document Format Files

Seq Description Document Type Size
1 S-8 d758019ds8.htm S-8 50675
2 EX-5.1 d758019dex51.htm EX-5.1 7013
3 EX-23.1 d758019dex231.htm EX-23.1 2012
4 EX-99.1 d758019dex991.htm EX-99.1 96342
5 EX-FILING FEES d758019dexfilingfees.htm EX-FILING FEES 19677
6 GRAPHIC g758019g66z86.jpg GRAPHIC 2789
  Complete submission text file 0001193125-24-282019.txt   180859
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283935 | Film No.: 241563418
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)